Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

0.631
Delayed Data
As of Jun 23
 -0.004 / -0.63%
Today’s Change
0.60
Today|||52-Week Range
2.65
-47.42%
Year-to-Date
No recent news for ContraVir Pharmaceuticals Inc.

Today’s Trading

Previous close0.64
Today’s open0.63
Day’s range0.62 - 0.64
Volume406,986
Average volume (3 months)1,088,506
Market cap$47.8M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+38.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BLPHBellerophon Therapeu...+0.08+5.84%
OREXOrexigen Therapeutic...+0.03+0.97%
GNMXAevi Genomic Medicin...-0.04-3.03%
RGLSRegulus Therapeutics...-0.07-7.58%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 30, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$17.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
James E. Sapirstein
Chief Financial Officer
John T. Cavan
Corporate headquarters
Edison, New Jersey

Forecasts